BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9029481)

  • 1. Constitutively active G protein-coupled receptors: potential mechanisms of receptor activation.
    Scheer A; Cotecchia S
    J Recept Signal Transduct Res; 1997; 17(1-3):57-73. PubMed ID: 9029481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activity and inverse agonism at the alpha1adrenoceptors.
    Cotecchia S
    Biochem Pharmacol; 2007 Apr; 73(8):1076-83. PubMed ID: 17125741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of constitutive G protein-coupled receptor activity for drug discovery.
    Chen G; Way J; Armour S; Watson C; Queen K; Jayawickreme CK; Chen WJ; Kenakin T
    Mol Pharmacol; 2000 Jan; 57(1):125-34. PubMed ID: 10617687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.
    Seifert R; Wenzel-Seifert K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):381-416. PubMed ID: 12382069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.
    Ramsay D; Bevan N; Rees S; Milligan G
    Br J Pharmacol; 2001 May; 133(2):315-23. PubMed ID: 11350868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinase-inactive G-protein-coupled receptor kinases are able to attenuate follicle-stimulating hormone-induced signaling.
    Reiter E; Marion S; Robert F; Troispoux C; Boulay F; Guillou F; Crepieux P
    Biochem Biophys Res Commun; 2001 Mar; 282(1):71-8. PubMed ID: 11263973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis.
    Ganguli SC; Park CG; Holtmann MH; Hadac EM; Kenakin TP; Miller LJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):593-8. PubMed ID: 9694908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and functional analysis of G protein-coupled receptors and potential diagnostic ligands.
    Fraser CM
    J Nucl Med; 1995 Jun; 36(6 Suppl):17S-21S. PubMed ID: 7769460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control.
    Pathe-Neuschäfer-Rube A; Neuschäfer-Rube F; Püschel GP
    Biochem J; 2005 May; 388(Pt 1):317-24. PubMed ID: 15651980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.
    Scheer A; Fanelli F; Costa T; De Benedetti PG; Cotecchia S
    EMBO J; 1996 Jul; 15(14):3566-78. PubMed ID: 8670860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-Protein coupled receptors: models, mutagenesis, and drug design.
    Bikker JA; Trumpp-Kallmeyer S; Humblet C
    J Med Chem; 1998 Jul; 41(16):2911-27. PubMed ID: 9685229
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of constitutive activation or inactivation of the platelet-activating factor receptor by glutamate substitution of alanine 230.
    Carlson SA; Chatterjee TK; Fisher RA
    Recept Signal Transduct; 1996; 6(2):111-20. PubMed ID: 9015866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of constitutively active receptors for drug discovery at the G protein-coupled receptor gene pool.
    Behan DP; Chalmers DT
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):548-60. PubMed ID: 12825451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A database of mutants and effects of site-directed mutagenesis experiments on G protein-coupled receptors.
    Kristiansen K; Dahl SG; Edvardsen O
    Proteins; 1996 Sep; 26(1):81-94. PubMed ID: 8880932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis and peptide analysis of the DRY motif in the alpha2A adrenergic receptor: evidence for alternate mechanisms in G protein-coupled receptors.
    Chung DA; Wade SM; Fowler CB; Woods DD; Abada PB; Mosberg HI; Neubig RR
    Biochem Biophys Res Commun; 2002 May; 293(4):1233-41. PubMed ID: 12054508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
    Purohit A; Herrick-Davis K; Teitler M
    Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis reveals how G protein-coupled receptors transduce the signal to the G protein.
    Oliveira L; Paiva PB; Paiva AC; Vriend G
    Proteins; 2003 Sep; 52(4):553-60. PubMed ID: 12910455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple activation steps of the N-formyl peptide receptor.
    Prossnitz ER; Gilbert TL; Chiang S; Campbell JJ; Qin S; Newman W; Sklar LA; Ye RD
    Biochemistry; 1999 Feb; 38(8):2240-7. PubMed ID: 10029516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel constitutively active mutation in the second cytoplasmic loop of metabotropic glutamate receptor.
    Yamashita T; Kai T; Terakita A; Shichida Y
    J Neurochem; 2004 Oct; 91(2):484-92. PubMed ID: 15447681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.